Endoluminal RFA in pts with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/lrYsL54mYu
Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2023 – Dec 2024Where it's discussed
-
X / Twitter24 posts
-
YouTube2 videos
AI synopsis
What people are saying
The overall tone reflects pride and recognition of the study's importance, exemplified by praise for MUDr. Jany Jarošov á and mentions of awards, indicating respect and honor rather than critical evaluation. Words like 'proud,' 'best publication,' and 'important study' emphasize acknowledgment and appreciation, which contribute to a moderate agreement and engagement but suggest limited discussion on the clinical impacts or methodological debates.
Most discussions acknowledge the study's findings, with some expressing pride in the authors’ achievements, but few critique or challenge the outcomes.
The focus mainly revolves around recognizing the significance of the publication rather than exploring its detailed implications, leading to moderate interest.
Participants demonstrate active engagement by sharing accolades and emphasizing the importance of the research, indicating a committed but not deeply analytical discussion.
The discussions highlight recognition and pride within the medical community but lack evidence of driving immediate change or widespread debate.
Abstract in brief
- This study compared endoluminal radiofrequency ablation (RFA) combined with stenting to stenting alone in patients with malignant biliary obstruction, primarily caused by cholangiocarcinoma or pancreatic cancer, and found no significant difference in survival, stent patency, or quality of life between the two treatments.
- The trial included 161 patients and was stopped early for futility after interim analysis, showing that RFA did not improve overall survival or other secondary outcomes like adverse events compared to stenting alone.
- Overall, the results suggest that adding endoluminal RFA to stenting does not offer additional benefits for patients with malignant biliary obstruction.
Top posts
Most liked on X and BlueskyImportant study: RFA
Jsme pyšní na úspěch MUDr. Jany Jarošové, která získala ocenění za nejlepší publikaci ČLS JEP r. 2023 autorů do 35 let.
Jana Jarošová z Kliniky hepatogastroenterologie #IKEM byla oceněna Kasafírkovou cenou 2024 za nejlepší publikaci z ČR v oblasti gastroenterologie. Cenu vyhrála za publikaci Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomized trial.
Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/jKEjVdzIGa
Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial https://t.co/MvSLMPe8eo
All mentions
Endoluminal Radiofrequency Ablation for Malignant Biliary Obstruction Review
This study compares endoluminal radiofrequency ablation combined with stenting versus stenting alone in patients with malignant biliary obstruction, primarily caused by cholangiocarcinoma or pancreatic cancer, and found…
Endoluminal Radiofrequency Ablation in Malignant Biliary Obstruction: Efficacy and Outcomes
A recent study compared endoluminal radiofrequency ablation combined with stenting versus stenting alone in patients with malignant biliary obstruction, primarily caused by cholangiocarcinoma or pancreatic cancer…
Jana Jarošová z Kliniky hepatogastroenterologie #IKEM byla oceněna Kasafírkovou cenou 2024 za nejlepší publikaci z ČR v oblasti gastroenterologie. Cenu vyhrála za publikaci Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomized trial.
RT @ikemcz: Jsme pyšní na úspěch MUDr. Jany Jarošové, která získala ocenění za nejlepší publikaci ČLS JEP r. 2023 autorů do 35 let.
RT @ikemcz: Jsme pyšní na úspěch MUDr. Jany Jarošové, která získala ocenění za nejlepší publikaci ČLS JEP r. 2023 autorů do 35 let.
Jsme pyšní na úspěch MUDr. Jany Jarošové, která získala ocenění za nejlepší publikaci ČLS JEP r. 2023 autorů do 35 let.
RT @rcverdonk: Important study: RFA
RT @ArndtVogel: Endoluminal RFA in pts with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/lrYsL54mYu
RT @vural_A: Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial https://t.co/MvSLMPe8eo
Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial https://t.co/MvSLMPe8eo
RT @SyedAAhmad5: Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial @Gut_BMJ https:/…
Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/jKEjVdzIGa
RT @ArndtVogel: Endoluminal RFA in pts with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/lrYsL54mYu
RT @ArndtVogel: Endoluminal RFA in pts with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/lrYsL54mYu
RT @ArndtVogel: Endoluminal RFA in pts with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/lrYsL54mYu
RT @ArndtVogel: Endoluminal RFA in pts with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/lrYsL54mYu
RT @ArndtVogel: Endoluminal RFA in pts with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/lrYsL54mYu
Endoluminal RFA in pts with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/lrYsL54mYu
Endoluminal RFA in pts with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/lrYsL54mYu
Endoluminal RFA in pts with malignant biliary obstruction: a randomised trial @Gut_BMJ https://t.co/lrYsL54mYu
RT @rcverdonk: Important study: RFA
RT @rcverdonk: Important study: RFA
RT @rcverdonk: Important study: RFA
RT @rcverdonk: Important study: RFA
RT @rcverdonk: Important study: RFA
Important study: RFA